NOVONIX Ltd Files Form 6-K with ASX Announcement
Ticker: NVNXF · Form: 6-K · Filed: Nov 25, 2024 · CIK: 1859795
Sentiment: neutral
Topics: foreign-private-issuer, sec-filing, announcement
Related Tickers: NVX
TL;DR
NOVONIX Ltd dropped a 6-K filing with an ASX announcement attached. Check it for news.
AI Summary
NOVONIX Limited filed a Form 6-K on November 25, 2024, reporting information for the month of November 2024. The filing includes an ASX Announcement as Exhibit 99.1. NOVONIX Limited is incorporated in Australia and its principal executive office is located in Brisbane.
Why It Matters
This filing provides an update from NOVONIX Limited to the SEC, likely containing important operational or financial news for investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that typically contains updates or announcements, not significant financial events.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- 20241125 (date) — Filing Date
- November, 2024 (date) — Reporting Period
- Brisbane, QLD (location) — Principal Executive Office
- Exhibit 99.1 (document) — Included Exhibit
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the issuer makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is November 25, 2024.
What is the reporting period for this Form 6-K?
The reporting period for this Form 6-K is the month of November, 2024.
Where is NOVONIX Limited's principal executive office located?
NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
What is included as an exhibit in this filing?
Exhibit 99.1, an ASX Announcement, is included in this filing.
Filing Stats: 209 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-11-25 09:23:54
Filing Documents
- nvx-6k-nov-24-11-1125_po.htm (6-K) — 23KB
- nvx-ex99_1.htm (EX-99.1) — 26KB
- nvx-ex99_2.htm (EX-99.2) — 23KB
- img58969013_0.jpg (GRAPHIC) — 5KB
- img58969013_1.jpg (GRAPHIC) — 5KB
- img59892534_0.jpg (GRAPHIC) — 5KB
- img59892534_1.jpg (GRAPHIC) — 5KB
- 0000950170-24-130444.txt ( ) — 103KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: November 25, 2024